Powles T, et al. A phase II study investigating the safety and efficacy of savolitinib and durvalumab in metastatic papillary renal cancer (CALYPSO). ASCO-GU 2019, abstract 545.
Toename van darmkanker door vroege opsporing en vergrijzing
mrt 2017 | Maag-darm-leveroncologie